Gastric leiomyoma

disease
On this page

Also known as leiomyoma of stomachleiomyoma of the stomachstomach leiomyoma

Summary

Gastric leiomyoma (MONDO:0000938) is a disease and 1 clinical trial. A subtype of leiomyoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namegastric leiomyoma
Mondo IDMONDO:0000938
DOIDDOID:10087
ICD-11910186285
NCITC3876
SNOMED CT276812001
UMLSC0238440
MedGen116062
Anatomy (UBERON)UBERON:0000945
Is cancer (heuristic)no

Also known as: gastric leiomyoma · leiomyoma of stomach · leiomyoma of the stomach · stomach leiomyoma

Disease family

This is a subtype of leiomyoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermusculoskeletal system benign neoplasmbenign muscle neoplasm › benign smooth muscle neoplasm › leiomyomagastric leiomyoma

Related subtypes (29): laryngeal leiomyoma, ureter leiomyoma, vaginal leiomyoma, bladder leiomyoma, breast leiomyoma, small intestine leiomyoma, urethra leiomyoma, trachea leiomyoma, prostate leiomyoma, mediastinum leiomyoma, fallopian tube leiomyoma, central nervous system leiomyoma, bizarre leiomyoma, deep leiomyoma, leiomyoma cutis, lung leiomyoma, pericardium leiomyoma, leiomyomatosis, cellular leiomyoma, gallbladder leiomyoma, vulvar leiomyoma, colorectal leiomyoma, liver leiomyoma, esophagus leiomyoma, renal leiomyoma, myofibroma, uterine corpus leiomyoma, leiomyoma of ciliary body, benign metastasizing leiomyoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified1

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07454967Not specifiedCOMPLETEDDevelopment of a Multimodal AI System for GIST Management

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.